Anti-C1q autoantibodies

Autoimmunity Reviews

Volumn 7, Issue 8, 2008, Pages 612-615

  Kallenberg, Cees G M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Anti C1q autoantibodies; C1q; SLE nephritis

Indexed keywords

COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DOUBLE STRANDED DNA ANTIBODY; FC RECEPTOR;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; COMPLEMENT SYSTEM; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS; IMMUNE COMPLEX DISEASE; KIDNEY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; PATHOGENESIS; PREVALENCE; RELAPSE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; URTICARIA; VASCULITIS;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; COMPLEMENT C1Q; HUMANS;

EID: 51749117999     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.06.006     Document Type: Review

References (25)

1. Walport M.J. Complement. First of two parts. N Engl J Med 344 (2001) 1058-1066
2. Walport M.J. Complement. Second of two parts. N Engl J Med 344 (2001) 1140-1144
3. Walport M.J., Davies K.A., Morley B.J., and Botto M. Complement deficiency and autoimmunity. Ann N Y Acad Sci 815 (1997) 267-281
4. Würzner R., Orren A., and Lachman P.J. Inherited deficiencies of the terminal components of human complement. Immunodefic Rev 3 (1992) 123-147
5. Trouw L.A., Roos A., and Daha M.R. Autoantibodies to complement components. Mol Immunol 38 (2001) 199-206
6. Giles C.M., and Swanson J.L. Anti-C4 in the serum of a transfused C4-deficient patient with systemic lupus erythematosus. Vox Sang 46 (1984) 291-299
7. Appel G.B., Cook H.T., Hageman G., Jennette J.C., Kashgarian M., Kirschfink M., et al. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol 16 (2005) 1392-1403
8. Jackson J., Sim R.B., Whelan A., and Feighery C. An IgG autoantibody which inactivates C1-inhibitor. Nature 323 (1986) 722-724
9. Seelen M.A., Trouw L.A., and Daha M.R. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus. Curr Opin Nephrol Hypertens 12 (2003) 619-624
10. Mannik M., and Wener M. Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Arthritis Rheum 40 (1997) 1504-1511
11. Kohro-Kawata J., Wener M.H., and Mannik M. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus. J Rheumatol 29 (2002) 84-89
12. Norsworthy P., Theodondis E., Botto M Athanassiou P., Beynon H., Gordon C., Isenberg D., et al. Overrepresentation of the Fc-gamma receptor type IIA R131/R131 genotype in caucasoid systemic lupus erythematosus patients with autoantibodies to C1q and glomerulonephritis. Arthritis Rheum 42 (1999) 1828-1832
13. Coremans I.E., Daha M.R., van der Voort E.A., Siegert C.E., and Breedveld F.C. Subclass distribution of IgA and IgG antibodies against C1q in patients with rheumatic diseases. Scand J Immunol 41 (1995) 391-397
14. Wisnieski J.J., and Naff G.B. Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome. Arthritis Rheum 32 (1989) 1119-1127
15. Wisnieski J.J., and Jones S.M. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus. J Immunol 148 (1992) 1396-1403
16. Sinico R.A., Radice A., Ikehata M., Giammarresi G., Corace C., Arrigo G., et al. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance. Ann NY Acad Sci 1050 (2005) 193-200
17. Trendelenburg M., Lopez-Trascasa M., Potlukova E., Moll S., Regenass S., Frémeaux-Bacchi V., et al. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol Dial Transplant 21 (2006) 3115-3121
18. Marto N., Bertolaccini M.I., Calabuig E., Hughes G.R.V., and Khamashta M.A. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis 64 (2005) 444-448
19. Koryro I., Perahud I., Sadallah S., Sukalo A., Titov L., Schifferli J., and Trendelenburg M. Clinical value of autoantibodies against C1q in children with glomerulonephritis. Pediatrics 117 (2006) 1663-1668
20. Coremans I.E., Spronk P.E., Bootsma H., Daha M.R., van der Voort E.A., Kater L., Breedveld F.C., and Kallenberg C.G. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis 26 (1995) 595-601
21. Moroni G., Trendelenburg M., Del Papa N., Quaglini S., Raschi E., Panzeri P., Testoni C., Tincani A., Banfi G., Balestrieri G., Schifferli J.A., Meroni P.L., and Ponticelli C. Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis 37 (2001) 490-498
22. Norsworthy P., Theodoridis E., Botto M., Athanassiou P., Beynon H., Gordon C., Isenberg D., Walport M.J., and Davies K.A. Overrepresentation of the Fcγ receptor type IIA R131/R131 genotype in caucasoid systemic lupus erythematosus patients with autoantibodies to C1q and glomerulonephritis. Arthritis Rheum 42 (1999) 1828-1832
23. Trouw L.A., Groeneveld T.W., Seelen M.A., Duijs J.M., Bajema I.M., Prins F.A., Kishore U., Salant D.J., Verbeek J.S., van Kooten C., and Daha M.R. Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J Clin Invest 114 (2004) 679-688
24. Bijl M., Limburg P.C., and Kallenberg C.G.M. New insights into the pathogenesis of systemic lupus erythematosus: the role of apoptosis. Neth J Med 59 (2001) 66-75
25. Reefman E., Limburg P.C., Kallenberg C.GM., and Bijl M. Fcγ receptors in the initiation and progression of systemic lupus erythematosus. Ann N Y Acad Sci 1051 (2005) 52-63